Intezyne Competitors and Similar CompaniesClear all

Intezyne's competitors and similar companies include Ascentage Pharma, Chugai Pharmaceutical, Achilles Therapeutics and Epizyme.

	Intezyne Intezyne is a biopharmaceutical company leveraging its polymer technologies to develop cancer therapies.	Ascentage Pharma Ascentage Pharma Group International (亚盛闘棄集團) is a biopharmaceutical company that is engaged in discovering, developing, and commercializing therapies.	Chugai Pharmaceutical Chugai Pharmaceutical is a pharmaceutical company specializing in the fields of oncology, as well as bone, joint, and renal diseases.	Achilles Therapeutics Achilles Therapeutics is a developer of immunotherapies intended to offer therapies to treat cancer.	Epizyme Epizyme is a clinical stage biopharmaceutical company focusing on treatments for blood cancer and tumors.
Founding Date	Founding Date 2004	Founding Date 2017	Founding Date 1925	Founding Date 2016	Founding Date 2007
Type	Type Private	Type Public	Type Public	Type Private	Type Public
Tags	Tags Healthcare biotech oncology pharma polymers	Tags Healthcare biotech oncology pharma	Tags Healthcare biotech oncology pharma	Tags Healthcare biotech oncology pharma	Tags Healthcare biotech oncology pharma
Locations	Locations Tampa, US HQ	Locations Suzhou, CN HQ Guangzhou Shi, CN Suzhou Shi, CN Taizhou, CN Rockville, US	Locations Chuo City, JP HQ Guangzhou Shi, CN Taizhou, CN Puteaux, FR Frankfurt Am Main, DE Singapore, SG see more	Locations London, GB HQ Stevenage, GB	Locations Cambridge, US HQ
Employees	Employees 4	Employees 567	Employees 7,778	Employees 695% decrease	Employees 20364% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 78.7 b	Valuation ($) N/A	Valuation ($) 250.8 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) ¥574.1m (FY, 2025)	Revenue (est.) ¥1.3t (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $37.4m (FY, 2021)
Cost of goods	Cost of goods N/A	Cost of goods ¥48.9m (FY, 2025)	Cost of goods ¥363.7b (FY, 2025)	Cost of goods N/A	Cost of goods $10.5m (FY, 2021)
Gross profit	Gross profit N/A	Gross profit ¥546.6m (FY, 2025)	Gross profit ¥903.5b (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income N/A	Net income (¥1.2b) (FY, 2025)	Net income ¥434b (FY, 2025)	Net income ($69.7m) (FY, 2023)	Net income ($251.1m) (FY, 2021)
Funding
Latest funding round	Latest funding round $ 10m (over 8 years ago)	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 121m (over 6 years ago)	Latest funding round N/A
Total funding raised	Total funding raised $ 10.5m	Total funding raised $ 237.5m	Total funding raised N/A	Total funding raised $ 138.1m	Total funding raised $ 51.5m

For sources of this data, please see the company profile

View Company Profiles

Ascentage Pharma

Suzhou, CN

Employees

567

Ascentage Pharma Group International (亚盛闘棄集團) is a biopharmaceutical company that is engaged in discovering, developing, and commercializing therapies.

View company

Chugai Pharmaceutical

Chuo City, JP

Employees

7,778

Chugai Pharmaceutical is a pharmaceutical company specializing in the fields of oncology, as well as bone, joint, and renal diseases.

View company

Achilles Therapeutics

London, GB

Employees

69↓ 5% decrease

Achilles Therapeutics is a developer of immunotherapies intended to offer therapies to treat cancer.